Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Preferred Stock Liabilities (2017 - 2021)

Cogent Biosciences (COGT) has 3 years of Preferred Stock Liabilities data on record, last reported at $85.4 million in Q3 2021.

  • For Q3 2021, Preferred Stock Liabilities fell 38.22% year-over-year to $85.4 million; the TTM value through Sep 2021 reached $85.4 million, down 38.22%, while the annual FY2020 figure was $110.9 million, N/A changed from the prior year.
  • Preferred Stock Liabilities reached $85.4 million in Q3 2021 per COGT's latest filing, roughly flat from $85.4 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $138.2 million in Q3 2020 and bottomed at $77.2 million in Q1 2018.
  • Average Preferred Stock Liabilities over 3 years is $98.6 million, with a median of $90.0 million recorded in 2021.
  • The widest YoY moves for Preferred Stock Liabilities: up 38.22% in 2021, down 38.22% in 2021.
  • A 3-year view of Preferred Stock Liabilities shows it stood at $77.2 million in 2018, then soared by 43.69% to $110.9 million in 2020, then dropped by 22.98% to $85.4 million in 2021.
  • Per Business Quant database, its latest 3 readings for Preferred Stock Liabilities were $85.4 million in Q3 2021, $85.4 million in Q2 2021, and $94.7 million in Q1 2021.